ZYDUS WELLNESS LTD.-$ - 531335 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Intimation of loss of share certificate under Reg. 39(3) of the SEBI (LODR) Regulations, 201523-04-2024
23-04-2024
ZYDUS WELLNESS LTD.-$ - 531335 - Receipt Of Order Under CGST Act
Receipt of Order under CGST Act22-04-2024
Zydus Life Launches Generic Drug For Overactive Bladder In US
Zydus is among the first suppliers to launch the generic version of Mirabegron extended-release tablets (USP 25 mg) in the US market.22-04-2024
ZYDUS WELLNESS LTD.-$ - 531335 - Certificate Under Reg. 40(10) Of SEBI (LODR) Regulations, 2015
Certificate under Reg. 40(10) of SEBI (LODR) Regulations, 201509-04-2024
ZYDUS WELLNESS LTD.-$ - 531335 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Certificate under Regulation 74(5) of the SEBI (DP) Regulations, 2018 for the quarter ended on March 31, 202408-04-2024
ZYDUS WELLNESS LTD.-$ - 531335 - Certificate Under Reg. 7(3) Of The SEBI (LODR) Regulations, 2015 For The Financial Year Ended On March 31, 2024
Certificate under Reg. 7(3) of the SEBI (LODR) Regulations, 201503-04-2024
ZYDUS WELLNESS LTD.-$ - 531335 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Intimation of loss of share certificate under Reg. 39(3) of the SEBI (LODR) Regulations, 201503-04-2024
ZYDUS WELLNESS LTD.-$ - 531335 - Announcement under Regulation 30 (LODR)-Change in Management
Update on Senior Management01-04-2024
ZYDUS WELLNESS LTD.-$ - 531335 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Intimation of loss of share certificate under Reg. 39(3) of the SEBI (LODR) Regulations, 201529-03-2024
Zydus Lifesciences up marginally despite 4 observations from USFDA
USFDA inspected Zydus Lifesciences' Onco injectable manufacturing plant in Ahmedabad from March 18 to 2728-03-2024